Drug Type Small molecule drug |
Synonyms EX 14280, EX14280 |
Target |
Action inhibitors |
Mechanism FAAH inhibitors(Anandamide amidohydrolase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autism Spectrum Disorder | Preclinical | United States | 01 Jun 2025 | |
Phobia, Social | Preclinical | United States | 01 Jun 2025 |